The coronavirus pandemic keeps damaging the world’s economy and supply chains, and the cannabis sector is trying to cope with the high demands in many countries. In Germany, cannabis is a special case as the government doesn’t seem to care about its legalization. This is just another obstacle for the growing sector as consumers look into options to secure their cannabis supply.
The COVID-10 pandemic is affecting all economic sectors worldwide. The cannabis sector is definitely no exception.
In the US and Canada, where free citizens are allowed to buy cannabis, sales are increasing massively – the demand for this plant is understandably high in times of isolation and curfew. Unfortunately, in Germany, on the other hand, the government still has not decided to release cannabis.
Consequently, there is no foreseeable hemp harvest in Germany. In addition, according to some reports, pharmacies in Germany are running out of cannabis. The increasing shortage in the supply of cannabis medicine in Germany could be a big problem for patients.
If you want to know more about cannabis, how Germany is expected to handle its high demand for cannabis since the government has not yet legalized it, and to find out the latest cannabis news, download the Hemp.im mobile application.
Is the overseas cannabis sector in danger due to the coronavirus pandemic
In the United States, for example, the national government ignores the cannabis industry. It refuses to include cannabis companies in the financial plan to help businesses stay afloat. Consequently, slowly but surely more and more companies are getting into capital problems.
The restrictions and confinement measures will probably also reduce cannabis production. Consequently, it is currently hardly possible to estimate how much hemp and cannabis can be produced and exported.
Clearly there are many bankruptcies threatening the cannabis sector and that is not good news for a country like Germany and its patients, which is totally dependent on cannabis imports.
Germany is looking for ways to meet the increasing cannabis demand
The popularity of cannabis in Germany is now in an almost fatal disproportion compared to the views of politicians. The current figures showed that in the past year alone, several million euros were spent on medical cannabis prescriptions, which were often covered by health insurance.
After endless delays, the government also issued some cultivation licenses, but much too late and, as usual, not enough taking into account the real demand. Ten tons of cannabis over four years – that will not be enough back and forth. Those responsible know this very well, but have been calculating for years with deliberate shortages.
Are politicians to be blame for the lack of cannabis supplies
Politicians have recently reflected on the value of life in times of the coronavirus pandemic. However, they do nothing for the cannabis industry. Officials promised a lot and are thus directly responsible for the suffering of the patients, even without government involvement.
Ignorance is running through all instances and in the end, more and more sick people end up in pharmacies and are told that the highly effective and popular cannabis medicine is once again not available.
Of course, growing cannabis in Germany is officially not allowed, but what should patients do? Cannabis is always sold out and the situation is likely to get worse because of the COVID-19 pandemic and the difficult supply. Consequently, many people chose to plant cannabis on their own, especially during spring, either indoor with a lamp or outdoors in their garden.
Therefore, medical cannabis patients in Germany can be sure of the quality of cannabis they use. With the help of the custom-fit seeds available on the Internet, consumers can also grow the hemp plants for personal needs.
Regardless of the medical indication – self-sufficiency is unfortunately often necessary in Germany and almost indispensable for cannabis in view of the poor supply situation.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in THC.guide, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.